As USP14 is a major regulator of the proteasome and possesses proteasome-associated deubiquitination activity [39], we treated NPC cells with MG132, a proteasome suppressor that impedes ubiquitin degradation. This evidence concerns the gene USP14 and nasopharyngeal carcinoma.